No takes yet. Share an insight, caveat, or question.
This article analyzes ICSID jurisdiction and alternative dispute resolution avenues, suggesting implications for states and investors.
Dmitry Semenovich Belkin (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: